Atherosclerosis and lupus: What we know and what we should know

Journal of Rheumatology

Volumn 36, Issue 11, 2009, Pages 2380-2382

  Doria, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; THALLIUM 201; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DRUG MECHANISM; EDITORIAL; ELECTRON BEAM TOMOGRAPHY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INTRAVASCULAR ULTRASOUND; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; ATHEROSCLEROSIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RISK FACTORS;

EID: 70450175971     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090999     Document Type: Editorial

References (20)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of SLE. Am J Med 1976;60:221-225
2. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006;119:700-706 (Pubitemid 44128446)
3. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975;58:243-264
4. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turiel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-686 (Pubitemid 41413291)
5. Bruce IN. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology 2005;44:1492-1502
6. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-2406 (Pubitemid 37542988)
7. Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007;34:937-942 (Pubitemid 46774835)
8. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008;121 Suppl 1:S21-31.
9. Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis - Basic mechanisms. Rheum Dis Clin North Am 2005;31:329-354
10. Bassi N, Zampieri S, Ghirardello A, Tonon M, Zen M, Cozzi F, et al. Pentraxins, anti-pentraxin antibodies, and atherosclerosis. Clin Rev Allergy Immunol 2009;37:36-43.
11. Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, et al. OxLDL/beta 2 GPI-anti-oxLDL/beta 2 GPI complex and atherosclerosis in SLE patients. Autoimmun Rev 2007;7:52-58
12. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. N Engl J Med 2004;350:1571-1575
13. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1071-1077 (Pubitemid 37323571)
14. Doria A, Briani C. Primary prevention of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008;4:576-577
15. Doria A, Arienti S, Rampudda M, Canova M, Tonon M, Sarzi-Puttini P. Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 2008;7:192-197
16. Doria A, Briani C. Lupus: improving long-term prognosis. Lupus 2008;17:166-170
17. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2009 Aug 28. [Epub ahead of print]
18. Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009;120:417-426
19. Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA. Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum 2008;59:1821-1824
20. Goldberg RJ, Urowitz MB, Ibañez D, Nikpour M, Gladman DD. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J Rheumatol 2009;36:2454-2461